Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
245 participants
INTERVENTIONAL
2018-03-14
2021-09-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Investigation of the Clareon® Intraocular Lens (IOL)
NCT03170154
Post-Market Clinical Survey of Clareon® IOL AutonoMe™ in Japanese Subjects
NCT03824028
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
NCT07161635
A Study Comparing Two Monofocal, Aspheric, Hydrophobic Acrylic Intraocular Lenses: the Alcon CLAREON® and the Abbott Medical Optics PCB00
NCT03364972
Clareon PanOptix Pro vs. Clareon PanOptix - Study B
NCT06401551
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clareon IOL
Clareon® aspheric hydrophobic acrylic intraocular lens implanted with the Alcon Monarch III-D delivery system as a replacement of the human crystalline lens during cataract surgery
Clareon® IOL
Foldable, single-piece posterior chamber IOL intended for long-term use over the lifetime of the cataract patient. This device is CE-marked (European Conformity) in the countries with participating Investigators.
Cataract Surgery
Routine small incision cataract surgery with unilateral IOL implantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clareon® IOL
Foldable, single-piece posterior chamber IOL intended for long-term use over the lifetime of the cataract patient. This device is CE-marked (European Conformity) in the countries with participating Investigators.
Cataract Surgery
Routine small incision cataract surgery with unilateral IOL implantation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned small incision cataract removal surgery
* Able to comprehend and willing to sign a statement of informed consent and complete all required post-implantation visits
Exclusion Criteria
* Certain eye conditions, as specified in the protocol, including but not limited to glaucoma, diabetic retinopathy, diabetic macular edema, and macular degeneration
* Pregnant or lactating, current or planned during the course of the study
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sr. Clinical Trial Lead, CDMA, Surgical
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon Investigative Site
Footscray, Victoria, Australia
Alcon Investigative Site
Mornington, Victoria, Australia
Alcon Investigative Site
Sydney, , Australia
Alcon Investigative Site
Brest, Cedex, France
Alcon Investigative Site
Lyon, , France
Alcon Investigative Site
Paris, , France
Alcon Investigative Site
Frankfurt, , Germany
Alcon Investigative Site
Heidelberg, , Germany
Alcon Investigative Site
Perugia, , Italy
Alcon Investigative Site
Pisa, , Italy
Alcon Investigative Site
Amsterdam, , Netherlands
Alcon Investigative Site
Jerez de la Frontera, Cadiz, Spain
Alcon Investigative Site
Alcalá de Henares, , Spain
Alcon Investigative Site
Oviedo, , Spain
Alcon Investigative Site
San Sebastián, , Spain
Alcon Investigative Site
Valencia, , Spain
Alcon Investigative Site
Sutton, Carshalton, United Kingdom
Alcon Investigative Site
Brighton, , United Kingdom
Alcon Investigative Site
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILJ466-P003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.